Weider Announces Fiscal 2004 First Quarter Results

SALT LAKE CITY, Utah--(BUSINESS WIRE)--Sept. 25, 2003--Weider Nutrition International, Inc. (NYSE: WNI) today announced results for the fiscal 2004 first quarter ended August 31, 2003.

Weider Nutrition's net sales were $63.6 million for the fiscal 2004 first quarter, compared to $69.3 million for the same period in fiscal 2003. Fiscal 2003 first quarter net sales include $3.1 million relating to the American Body Building(TM) and Science Foods(R) businesses, which were sold in that quarter. For its fiscal 2004 first quarter, Weider Nutrition reported net income of $2.2 million, or $0.08 per share (diluted), compared to a net loss of $10.9 million, or $0.42 per share, for the same period a year ago. The prior year quarter reflects the impact of adopting SFAS No. 142, which resulted in an after-tax charge of $15.4 million for the write-off of certain goodwill.

Bruce Wood, president and CEO, stated, "We began fiscal 2004 with a strengthened financial position, which has allowed us to continue implementation of marketing programs aimed at growing our flagship Move Free(R) joint care brand and the global Weider(R) brand. We were encouraged that our first quarter results may indicate revenues have started to stabilize. Furthermore, we were able to generate positive earnings per share, even while continuing our marketing efforts to grow our Move Free brand in fiscal 2004."

About Weider Nutrition

Weider Nutrition International, Inc. develops, manufactures, markets and sells branded and private label vitamins, nutritional supplements and sports nutrition products in the United States and throughout the world. To learn more about Weider, please visit the Web site www.weider.com.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended, that are based on management's beliefs and assumptions, current expectations, estimates, and projections. These statements are subject to risks and uncertainties, certain of which are beyond the company's ability to control or predict, and, therefore, actual results may differ materially. Weider Nutrition disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

Important factors that may cause these forward looking statements to be false include, but are not limited to: the inability to successfully implement marketing and spending programs behind our Move Free(R) brand and other branded new products, the inability to achieve cost savings and operational efficiencies, the inability to increase operating margins and increase revenues, dependence on individual products, the inability to successfully restructure the Haleko business unit and make it profitable, dependence on individual customers, the impact of competitive products and pricing (including private label), market and industry conditions (including pricing, demand for products, level of trade inventories and raw materials availability and pricing), the success of product development and new product introductions into the marketplace, changes in laws and regulations, litigation and government regulatory action, lack of available product liability insurance for products containing ephedra, uncertainty of market acceptance of new products, adverse publicity regarding the consumption of nutritional supplements, changes in accounting standards, and other factors indicated from time to time in our SEC reports, copies of which are available upon request from our investor relations department or may be obtained at the SEC's website (www.sec.gov).

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.